-
Mashup Score: 0
Converting operating rooms into those that are able to filter surgical smoke and biological contaminants can make workplaces safer for nurses and other health care staff.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Adding capivasertib to fulvestrant was shown to improve the time to second progression in patients with pretreated HR-positive, HER2-negative advanced breast cancer.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Over 500 attendees at this in-person event celebrated the incredible efforts made by oncology nurses when caring for patients with cancer.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
Uproleselan plus chemotherapy missed the overall survival end point in the phase 3 trial assessing the combination in patients with relapsed/refractory acute myeloid leukemia.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Trastuzumab Deruxtecan Provides Long-Term Survival Benefit for HER2+ Metastatic Breast Cancer - 8 day(s) ago
Compared with physician’s choice of treatment, trastuzumab deruxtecan exhibited superior long-term survival and response rates in patients with HER2-positive breast cancer.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Oncology nurses can discuss dose modifications for common smoking cessation agents with patients and providers to improve smoking cessation rates.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Atezolizumab Plus Chemo Did Not Improve Survival in TNBC - 9 day(s) ago
Compared with chemotherapy alone, atezolizumab plus chemotherapy did not improve overall survival in select patients with early relapsing triple-negative breast cancer.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Approval of Infigratinib Withdrawn by the FDA for Advanced FGFR2+ Cholangiocarcinoma - 10 day(s) ago
The accelerated approval of infigratinib has been withdrawn by the FDA for previously treated, FGFR2-positive, advanced cholangiocarcinoma.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Adjuvant Vaccine Combo May Prolong Survival in Melanoma - 10 day(s) ago
A multipeptide vaccine combination approach may extend survival in stage IIB to IV melanoma.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
The BLA for zenocutuzumab to treat NRG1-positive non–small cell lung cancer and pancreatic cancer received priority review from the FDA.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
Converting operating rooms into those that are able to filter surgical smoke and biological contaminants can make workplaces safer for nurses and other health care staff. @AHNtoday https://t.co/XBjBgS9qbH